They found that ALDH-positive CTCs and triple-positive CTCs were significantly associated with worse survival by univariate analysis, and ALDH-positive CTCs, triple-positive CTCs, and dual cytokeratin- and CD133-positive CTCs were not only independent predictors of tumor recurrence but were also associated with shorter disease-free survival [55]. Here, PROM1 is linked to neoplasm.